ABVC
Price
$0.92
Change
+$0.04 (+4.55%)
Updated
Apr 24, 04:57 PM (EDT)
Capitalization
14.37M
KNSA
Price
$20.56
Change
-$0.32 (-1.53%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.49B
11 days until earnings call
Ad is loading...

ABVC vs KNSA

Header iconABVC vs KNSA Comparison
Open Charts ABVC vs KNSABanner chart's image
ABVC BioPharma
Price$0.92
Change+$0.04 (+4.55%)
Volume$310
Capitalization14.37M
Kiniksa Pharmaceuticals International
Price$20.56
Change-$0.32 (-1.53%)
Volume$6.68K
Capitalization1.49B
ABVC vs KNSA Comparison Chart
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVC vs. KNSA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Hold and KNSA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ABVC: $0.91 vs. KNSA: $20.56)
Brand notoriety: ABVC and KNSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 14% vs. KNSA: 52%
Market capitalization -- ABVC: $14.37M vs. KNSA: $1.49B
ABVC [@Biotechnology] is valued at $14.37M. KNSA’s [@Biotechnology] market capitalization is $1.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 0 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • ABVC’s FA Score: 0 green, 5 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, KNSA is a better buy in the long-term than ABVC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 2 TA indicator(s) are bullish while KNSA’s TA Score has 5 bullish TA indicator(s).

  • ABVC’s TA Score: 2 bullish, 5 bearish.
  • KNSA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KNSA is a better buy in the short-term than ABVC.

Price Growth

ABVC (@Biotechnology) experienced а +6.55% price change this week, while KNSA (@Biotechnology) price change was +1.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

ABVC is expected to report earnings on Apr 15, 2025.

KNSA is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($1.49B) has a higher market cap than ABVC($14.4M). ABVC YTD gains are higher at: 47.305 vs. KNSA (3.943). ABVC has higher annual earnings (EBITDA): -6.36M vs. KNSA (-43.92M). KNSA has more cash in the bank: 244M vs. ABVC (208K). ABVC has less debt than KNSA: ABVC (2.33M) vs KNSA (9.86M). KNSA has higher revenues than ABVC: KNSA (423M) vs ABVC (510K).
ABVCKNSAABVC / KNSA
Capitalization14.4M1.49B1%
EBITDA-6.36M-43.92M14%
Gain YTD47.3053.9431,200%
P/E RatioN/A164.54-
Revenue510K423M0%
Total Cash208K244M0%
Total Debt2.33M9.86M24%
FUNDAMENTALS RATINGS
ABVC vs KNSA: Fundamental Ratings
ABVC
KNSA
OUTLOOK RATING
1..100
1453
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
9591
PRICE GROWTH RATING
1..100
3860
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABVC's Valuation (72) in the null industry is in the same range as KNSA (85) in the Pharmaceuticals Major industry. This means that ABVC’s stock grew similarly to KNSA’s over the last 12 months.

KNSA's Profit vs Risk Rating (62) in the Pharmaceuticals Major industry is somewhat better than the same rating for ABVC (100) in the null industry. This means that KNSA’s stock grew somewhat faster than ABVC’s over the last 12 months.

KNSA's SMR Rating (91) in the Pharmaceuticals Major industry is in the same range as ABVC (95) in the null industry. This means that KNSA’s stock grew similarly to ABVC’s over the last 12 months.

ABVC's Price Growth Rating (38) in the null industry is in the same range as KNSA (60) in the Pharmaceuticals Major industry. This means that ABVC’s stock grew similarly to KNSA’s over the last 12 months.

KNSA's P/E Growth Rating (1) in the Pharmaceuticals Major industry is significantly better than the same rating for ABVC (100) in the null industry. This means that KNSA’s stock grew significantly faster than ABVC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABVCKNSA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RARE37.311.40
+3.90%
Ultragenyx Pharmaceutical
NXTT0.280.01
+3.65%
Next Technology Holding
ATLX4.060.06
+1.50%
Atlas Lithium Corp
BBSI40.350.24
+0.60%
Barrett Business Services Inc.
NOK5.310.03
+0.57%
Nokia Corp

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
+4.52%
KNSA - ABVC
40%
Loosely correlated
+4.20%
MRSN - ABVC
33%
Loosely correlated
+2.39%
MLEC - ABVC
31%
Poorly correlated
-9.65%
FULC - ABVC
27%
Poorly correlated
-1.64%
MDXXF - ABVC
25%
Poorly correlated
N/A
More

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
-1.53%
BEAM - KNSA
40%
Loosely correlated
+1.51%
ABVC - KNSA
40%
Loosely correlated
+4.00%
IOVA - KNSA
38%
Loosely correlated
+5.33%
RGNX - KNSA
38%
Loosely correlated
+3.72%
CLDX - KNSA
37%
Loosely correlated
+0.77%
More